Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T21874 |
CID 2745687
|
GPR | Endocrinology/Hormones; GPCR/G Protein |
CID 2745687 是可逆的、特异性 GPR35竞争性拮抗剂(Ki:12.8 nM)。 | |||
T8423 |
ML417
|
Dopamine Receptor; Arrestin | GPCR/G Protein; Neuroscience |
ML417 是选择性的,可透过血脑屏障的 D3 多巴胺受体激动剂,EC50=38 nM。它能够促进 D3R 介导的 β-arrestin 易位、G 蛋白介导的信号传导和 pERK 磷酸化,对其他 GPCR 介导的信号传导影响小。它对毒素诱导的多巴胺能神经元变性具有神经保护活性。 | |||
T26869 |
BMS-986122
BMS 986122 |
Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
BMS-986122 (BMS 986122) 是选择性 μ 阿片受体正变构调节剂,可增加 β-抑制蛋白募集、腺苷酸环化酶抑制和 G 蛋白活化的作用,还增强 DAMGO 介导的 [35S]GTPγS 在小鼠脑膜中的结合。 | |||
T28073 |
MLS1547
MLS000051547,MLS 1547,MLS-1547 |
Dopamine Receptor | GPCR/G Protein; Neuroscience |
MLS1547 (MLS000051547) 是一种高效的 G 蛋白偏向多巴胺 D2 受体激动剂,Ki 为 1.2 μM。 MLS1547 在钙动员试验中刺激 D2R G 蛋白介导的信号传导,EC50 为 0.37 μM。 | |||
T12006 |
Metarrestin
ML246 |
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Metarrestin (ML246) 是一种口服有效的选择性核仁周区室 (PNC) 抑制剂,可有效抑制转移。Metarrestin 破坏核仁结构并抑制 RNA 聚合酶 (Pol) I 转录,部分是通过与翻译延伸因子 eEF1A2 的相互作用。 | |||
T15183 |
Dynarrestin
|
Hedgehog/Smoothened | GPCR/G Protein; Stem Cells |
Dynarrestin 是一种细胞质动力蛋白 1 和 2的氨基噻唑抑制剂。它能够快速的、可逆的抑制动力蛋白 1 驱动的微管在体外滑动和细胞内动力蛋白 1 和 2 依赖性过程,且不影响 ATP 水解和干扰纤毛发生。它可抑制神经元前体和肿瘤细胞的刺猬因子依赖性增殖。 | |||
T61562 |
CB1R Allosteric modulator 3
|
cAMP; Cannabinoid Receptor | GPCR/G Protein |
CB1R Allosteric modulator 3 是一种有效的 CB1R 调制剂。CB1R Allosteric modulator 3 抑制 cAMP 和 β-Arrestin ,可用于研究肥胖和尼古丁成瘾。 | |||
T23434 |
GPR35 agonist 2
TC-G 1001 |
GPR; Arrestin | Endocrinology/Hormones; GPCR/G Protein |
GPR35 agonist 2 (TC-G 1001) 是一种有效的 GPR35 激动剂。GPR35 agonist 2 在 β-arrestin 和 Ca2+ 释放试验中的 EC50 值分别为 26 和 3.2 nM。 | |||
T33452 |
ML192
ML-192,CID1434953,CID 1434953,ML 192,CID-1434953 |
Cannabinoid Receptor; GPR; Arrestin | Endocrinology/Hormones; GPCR/G Protein |
ML192 (CID1434953) 是一种具有选择性的 GPR55 配体拮抗剂。ML192 是一种抑制剂,可抑制 β-arrestin 转运、ERK1/2 磷酸化和 PKCβII 易位。 | |||
T4390 |
ML221
|
Apelin receptor; Arrestin | GPCR/G Protein |
ML221 是apelin (APJ)拮抗剂,能够抑制 apelin-13 介导的 APJ 的活化,在 cAMP 试验和 β-arrestin 实验中,IC50值分别为 0.70 μM 和 1.75 μM,EC80值均为 10 nM。 | |||
TP2158 |
TRV-120027 TFA
TRV-120027 TFA (1234510-46-3 free base) |
RAAS; Arrestin | Endocrinology/Hormones; GPCR/G Protein |
TRV-120027 TFA 是一种血管紧张素 II 介导的血管收缩抑制剂,可增加心肌细胞的收缩力。它是一种偏向 β-arrestin-1 的 AT1R 激动剂,可与 ß-arrestins 结合,同时阻断 G 蛋白信号传导。 它通过阳离子通道亚家族 C3 (TRPC3) 偶联诱导急性儿茶酚胺分泌,并促进在质膜上形成由 AT1R-β-arrestin-1-TRPC3-PLCγ 组成的大分子复合物。 | |||
TP1923L1 |
ELA-14(human) acetate
ELA-14(human) acetate (1886973-05-2 free base) |
Apelin receptor; Arrestin | GPCR/G Protein |
ELA-14(human) acetate 是 ELA 的一个片段,它与 APJ 结合,激活 Gαi1 和 β-arrestin-2 信号通路,并类似于其亲本内源性肽诱导受体内化。 | |||
TP1922L1 |
ELA-11 (human) acetate(1784687-32-6 free base)
|
Apelin receptor; Arrestin | GPCR/G Protein |
ELA-11 (human) acetate(1784687-32-6 free base)是亲和力 apelin 受体激动剂 (Ki = 14 nM)。 ELA-32 的生物活性片段。在体外抑制毛喉素诱导的 cAMP 产生并刺激 β-arrestin 募集。 | |||
TP2112L |
TC14012 acetate
TC14012 acetate(368874-34-4 free base) |
CXCR; Arrestin | Autophagy; GPCR/G Protein; Immunology/Inflammation |
TC14012 acetate 是 T140 的血清稳定衍生物,是一种选择性的肽模拟 CXCR4 拮抗剂,IC50 为 19.3 nM。 TC14012 还是一种有效的 CXCR7 激动剂,EC50 为 350 nM,可将 β-arrestin 2 募集到 CXCR7。 TC14012 具有抗癌活性和抗 HIV 活性。 | |||
TP2158L1 |
TRV-120027 acetate (1234510-46-3 free base)
|
RAAS; Arrestin | Endocrinology/Hormones; GPCR/G Protein |
TRV-120027 acetate (1234510-46-3 free base) 是 1 型血管紧张素 II 受体(AT1 受体)的 β-arrestin-1 偏向激动剂,可与 ß-arrestins 结合,同时阻断 G 蛋白信号传导。 | |||
T77673 |
7-FluorotryptaMine HCl
|
GPR; Arrestin | Endocrinology/Hormones; GPCR/G Protein |
7-FluorotryptaMine HCl 是一种有效的芳香单胺 GPRC5A 激动剂,可诱导 GPRC5A 介导的 β-arrestin 募集。7-FluorotryptaMine HCl 可用于研究与免疫和癌症相关的信号通路。 | |||
T41231 |
GP 1a
|
Cannabinoid Receptor; PERK; Arrestin | Apoptosis; GPCR/G Protein |
GP 1a 是cannabinoid receptor 2(CB2)的强效激动剂(EC50=7.1),是在cAMP、GTPγS 和β-arrestin 招募试验中显示的。GP 1a 对CB2受体的选择性约为CB1受体的30倍,且在体外增加HL-60细胞的P-ERK1/2表达。GP 1a 对皮肤伤口愈合有益。GP 1a 可抑制炎症和纤维生成,同时促进上皮的重新形成。 | |||
T33613 |
NCGC00135472
NCGC 00135472,DRV1 (GPR32) agonist C2A,C2A,NCGC-00135472 |
Others | Others |
NCGC00135472 (DRV1 (GPR32) agonist C2A)是具有促分解功能的人Resolvin D1受体激动剂,可在β阻滞素和 cAMP 测定中激活人溶解蛋白 D1 受体 DRV1/GPR32 受体,EC50 分别为 0.37 uM 和 0.05 uM。NCGC00135472在过表达重组DRV1的细胞中引起快速阻抗变化,刺激血清处理的酶聚糖的吞噬作用。 | |||
T29065 |
UNC9994
UNC-9994,UNC 9994 |
||
UNC9994 is a β-arrestin-biased dopamine D₂ receptor agonist (β-arrestin EC50 = 50 nM; Emax = 97%) with robust in vivo antipsychotic drug-like activities. | |||
T29061 |
UNC0006
UNC 0006,UNC-0006 |
||
UNC0006 is a β-arrestin-biased dopamine D2 ligand. | |||
T29064 |
UNC9975
UNC-9975 |
||
UNC9975 is an analog of aripiprazole and a β-arrestin-biased D2R agonist. | |||
T29066 |
UNC9995
UNC-9995,UNC 9995 |
||
UNC9995 is a β-Arrestin-Biased Dopamine D2 Receptor agonist (β-Arrestin, EC50 = 120 nM; Emax = 88%). | |||
T61371 | CB1R Allosteric modulator 4 | ||
CB1R Allosteric modulator 4 is an effective and positive modulator of cannabinoid type-1 (CB1R), exhibiting significant biological activity. This compound inhibits the production of cAMP and demonstrates strong β-arrestin-2 recruitment [1]. | |||
T70040 | BRD5814 | ||
BRD5814 is a highly brain penetrant β-arrestin biased D2R antagonist. | |||
T10926L | CYT-1010 hydrochloride | Others | Others |
CYT-1010 hydrochloride is an mu-opioid receptor agonist. The EC50 for β-arrestin recruitment and cAMP production inhibition were 13.1 nM and 0.0053 nM, respectively. | |||
T23866 |
CCX777
CCX 777,CCX-777 |
Arrestin | GPCR/G Protein |
CCX777 是 β-arrestin-2 招募到 ACKR3 的部分激动剂,可用于研究癌症。 | |||
T79312 |
FGH31
|
Dopamine Receptor | GPCR/G Protein; Neuroscience |
FGH31 (Compound 24) 作为选择性GRK2依赖的dopamine D4激动剂,显示出Ki值为1.6 nM的高亲和力,并能部分激活β-arrestin。 | |||
T37304 |
5-OxoETE methyl ester
|
||
5-OxoETE methyl ester is an esterified form of the polyunsaturated keto acid 5-oxoETE . 5-OxoETE methyl ester is an agonist of oxoeicosanoid receptor 1 (OXER1; EC50 = 1.54 μM for β-arrestin recruitment) that has a higher maximal response than 5-oxoETE in a β-arrestin assay. | |||
T78736 |
D3R ligand 1
|
Dopamine Receptor | GPCR/G Protein; Neuroscience |
D3R ligand 1 (compound 23b) 是针对多巴胺受体D3R具有高效选择性的配体,拥有66 nM的Ki值,且包含THPB模板。此外,D3R ligand 1 同时作为基于G蛋白及β-arrestin信号传导路径的拮抗剂。 | |||
T10926 | CYT-1010 | Others | Others |
CYT-1010 is an mu-opioid receptor agonist. The EC50 for the inhibition of β-arrestin recruitment and cAMP production is 13.1 nM and 0.0053 nM, respectively. | |||
T80140 |
(Val3,Pro8)-Oxytocin
|
Oxytocin Receptor | Endocrinology/Hormones; GPCR/G Protein |
"(Val3,Pro8)-Oxytocin"为Gq依赖性途径的激动剂,同时作为β-arrestin结合及催产素受体(OXTR)内化作用的次级激动剂。 | |||
T62853 |
UNC9994 hydrochloride
|
||
UNC9994 hydrochloride 是一种功能选择性的、β-arrestin 偏向的多巴胺 D2受体 (D2R) 激动剂 (Ki: 79 nM),能够选择性激活 β- arresttin 招募和信号转导。UNC9994 hydrochloride 是一种 Gi 调节 cAMP 产生的拮抗剂,也是 D2R/β-arrestin-2 相互作用的部分激动剂,表现出精神稳定作用。 | |||
TP2158L |
TRV-120027
|
Others | Others |
TRV120027 is a β-arrestin-1-biased agonist of the angiotensin II receptor type 1. TRV120027 inhibits angiotensin II-mediated vasoconstriction and increases cardiomyocyte contractility. | |||
T79744 |
GPR55 agonist 4
|
||
GPR55agonist 4 (Compound 28),作为一种高选择性激动剂,对hGPR55 和 rGPR55 的EC50值分别为131 nM和1.41 nM,能有效诱导β-arrestin招募至人GPR55。 | |||
T70342 |
MRS542
|
||
MRS542 is a A3AR antagonist as found by cyclic AMP assays, and a partial agonist as found by beta-arrestin translocation. LUF6000 is responsible for the partial agonist nature of MRS542. | |||
T68247 |
PSB-KD107
|
||
PSB-KD107 is an agonist of the Cannabinoid-Activated Orphan G‑Protein-Coupled Receptor GPR18. PSB-KD107 displayed significantly higher potency and efficacy than THC, determined in a GPR18-dependent β-arrestin recruitment assay, and were found to be selective versus the CB-sensitive receptors CB1, CB2, and GPR55. | |||
T61964 |
RXFP3/4 agonist 2
|
RXFP receptor | GPCR/G Protein |
RXFP3/4 agonist 2 是一种高效的非肽双 RXFP3/4 激动剂,诱导 RXFP3 和 β-arrestin-2 之间的相互作用,可用于研究代谢异常引起的疾病。 | |||
T79721 |
GPR55 agonist 3
|
||
GPR55agonist 3 (Compound 26)作为一种高效GPR55激动剂,其EC50值针对hGPR55与rGPR55分别为0.239 nM和1.76 nM。此外,该化合物在EC50为6.2 nM的条件下可诱导β-arrestin招募至人类GPR55。 | |||
T64305 |
APJ receptor agonist 7
|
||
APJ receptor agonist 7 (化合物 37) 是一种口服具有活力的 APJ (apelin 受体) 激动剂 (Ki: 0.059 μM)。APJ receptor agonist 7 能够作用于钙 (EC50: 0.070 μM)、cAMP (EC50: 0.097 μM) 和 β-arrestin (EC50: 0.063 μM)。 | |||
T78735 |
D1R antagonist 1
|
Dopamine Receptor | GPCR/G Protein; Neuroscience |
D1R antagonist 1 (compound 12a),一种参与基于G蛋白和β-抑制蛋白的信号传导的D1R拮抗剂。 | |||
T10716 |
CCR7 Ligand 1
CCR7-Cmp2105 |
Others | Others |
CCR7 Ligand 1 (CCR7-Cmp2105) is an allosteric Ligand and antagonist for human CC chemokine receptor 7 (CCR7) with a Kd of 3 nM. CCR7 Ligand 1, thiadiazole-dioxide ligan, suppresses arrestin binding in response to activation by CCL19 with an IC50 of 7.3 μM | |||
TP1922 |
ELA-11(human)
ELA-11 (human) |
||
High affinity apelin receptor agonist (Ki = 14 nM). Bioactive fragment of ELA-32. Inhibits forskolin-induced cAMP production and stimulates β-arrestin recruitment in vitro. | |||
T76053 |
ELA-11(human) TFA
|
||
ELA-11(human) TFA is a high affinityapelin receptoragonist (Ki=14 nM). ELA-11(human) TFA is a bioactive fragment of ELA-32. ELA-11(human) TFA inhibits forskolin-induced cAMP production and stimulates β-arrestin recruitment in vitro. | |||
TP1923 |
Elabela(19-32)
ELA-14 (human) |
||
Potent apelin (APJ) receptor agonist (Ki = 0.93 nM). Bioactive fragment of ELA-32. Activates Gαi1 pathway and β-arrestin-2 recruitment. Reduces arterial pressure in rat hearts. Active in vivo. | |||
T76044 |
Elabela(19-32) TFA
|
||
Elabela(19-32) TFA 是ELABELA(ELA)与apelin受体(APJ)结合的活性片段,能激活Gαi1和β-arrestin-2信号通路,EC50值分别为8.6 nM和166 nM。该化合物可诱导受体内在化,降低动脉压,并对心脏具有正性肌力作用。 | |||
T73690 |
Abaloparatide
|
||
Abaloparatide (BA 058) 是一种甲状旁腺激素受体 1 (PTHR1) 类似物。Abaloparatide 也是一种选择性 PTHR1激活剂。Abaloparatide 增强 Gs/cAMP 信号和β-arrestin 募集。Abaloparatide 可增强小鼠的骨形成和皮质结构。Abaloparatide 具有用于骨质疏松症研究的潜力。 | |||
T69824 | PSB-17365 | ||
PSB-17365 is a potent GPR84 agonist. PSB-17365 exhibits EC50 values vs. GPR84 of 2.5nM in a cAMP accumulation assay, and 100nM in a β-arrestin 2 recruitment assay. No direct binding affinities are provided. PSB-17365 is selective for GPR84 compared to other free fatty acid receptors (FFAR1 and FFAR4). GPR84, a Gi protein-coupled receptor that is activated by medium-chain (hydroxy)fatty acids, appears to play an important role in inflammation, immunity, and cancer. | |||
TP2141 |
Balixafortide TFA (1051366-32-5 free base)
Balixafortide TFA,POL6326 TFA |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
Balixafortide TFA (POL6326 TFA) is a selective, well-tolerated peptidic CXCR4 antagonist (IC50 < 10 nM). It shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide TFA blocks β-arrestin recruitment and calcium fl | |||
T14498 |
Barbadin
|
Arrestin | GPCR/G Protein |
Barbadin 是一种新型且具有特异性的 β-arrestin/β2-adaptin 相互作用抑制剂,对β-arestin1 的 IC50 值为 19.1 μM,对β-arestin2 的 IC50 值为 15.6 μM。Barbadin 增强氯卡色林对 POMC 神经元和减肥的长期影响,可阻断激动剂促进的原型 β2-肾上腺素能、V2-血管加压素和血管紧张素-II-1 型受体的内吞,可用于研究肥胖。 | |||
T36923 |
CXCR2-IN-2
CXCR2-IN-2 |
||
CXCR2-IN-2 is a selective, brain penetrant, and orally bioavailable CXCR2 antagonist (IC50=5.2 nM/1 nM in β-arrestin assay/CXCR2 Tango assay, respectively). CXCR2-IN-2 displays ~730-fold selectivity over CXCR1 and >1900-fold selectivity over all other chemokine receptors. CXCR2-IN-2 inhibits human whole blood Gro-α induced CD11b expression with an IC50 of 0.04 μM[1]. CXCR2-IN-2 (compound 68) (1-10 mg/kg; p.o.; twice daily for 3 days) dose-dependently reduces neutrophil infiltration in vivo in ra... |